Role and Relevance of PEPT2 in Drug Disposition, Dynamics, and Toxicity

Daniel, 2004, The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology, Pflugers Arch., 447, 610, 10.1007/s00424-003-1101-4 Herrera-Ruiz, 2002, Current perspectives on established and putative mammalian oligopeptide transporters, J. Pharm. Sci., 92, 691, 10.1002/jps.10303 Fei, 1994, Expression cloning of a mammalian proton-coupled oligopeptide transporter, Nature (Lond), 368, 563, 10.1038/368563a0 Lui, 1995, Molecular cloning of PEPT2, a new member of the H +/peptide cotransporter family from human kidney, Biochem. Biophys. Acta., 1235, 461, 10.1016/0005-2736(95)80036-F Yamashita, 1997, Cloning and functional expression of a brain peptide/histidine transporter, J Biol. Chem., 272, 10205, 10.1074/jbc.272.15.10205 Sakata, 2001, Cloning of a lymphatic peptide/histidine transporter, J. Biochem., 356, 53, 10.1042/0264-6021:3560053 Botka, 2000, Human proton/oligopeptide transporter (POT) genes: identification of putative human genes using bioinformatics, AAPS Pharm. Sci., 2, 1, 10.1208/ps020216 Rubio-Aliaga, 2002, Mammalian peptide transporters as targets for drug delivery, Trends pharmac. Sci., 23, 434, 10.1016/S0165-6147(02)02072-2 Ogihara, 1996, Immunolocalization of H + /peptide cotransporter in rat digestive tract, Biochem. Biophys. Res. Commun., 220, 848, 10.1006/bbrc.1996.0493 Groneberg, 2001, Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1, Am. J. Physiol. Gastrointest. Liver Physiol., 281, G697, 10.1152/ajpgi.2001.281.3.G697 Shen, 1999, Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney, Am. J. Physiol., 276, F658 Liang, 1995, Human intestinal H + /peptide cotransporter, J. Biol. Chem., 270, 6456, 10.1074/jbc.270.12.6456 Boll, 1996, Expression cloning and functional characterization of the kidney cortex high-affinity proton-coupled peptide transporter, Proc. Natl. Acad. Sci. USA, 93, 284, 10.1073/pnas.93.1.284 Döring, 1998, Delta-aminolevulinic acid transport by intestinal and renal peptide transporters and its physiological and clinical implications, J Clin. Invest., 101, 2761, 10.1172/JCI1909 Berger, 1999, Distribution of peptide transporter PEPT2 mRNA in the rat nervous system, Anat. Embryol., 199, 439, 10.1007/s004290050242 Shen, 2004, Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain, Mol. Pharm., 1, 248, 10.1021/mp049944b Novotny, 2000, Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus, J. Neurochem., 75, 321, 10.1046/j.1471-4159.2000.0750321.x Shu, 2002, Role of PEPT2 in peptide/mimetic trafficking at the blood-cerebral fluid barrier: studies in rat choroid plexus epithelial cells in primary culture, J. Pharmacol. Exp. Ther., 301, 820, 10.1124/jpet.301.3.820 Teuscher, 2000, Functional evidence for the presence of PEPT2 in rat choroid plexus: Studies with glycylsarcosine, J. Pharmacol. Exp. Ther., 294, 494 Teuscher, 2001, PEPT2-mediated uptake of neuropeptides in rat choroid plexus, Pharm. Res., 18, 807, 10.1023/A:1011088413043 Groneberg, 2001, Expression of PEPT2 peptide transporter mRNA and protein in glial cells of rat dorsal root ganglia, Neurosci. Lett., 304, 181, 10.1016/S0304-3940(01)01794-3 Groneberg, 2001, Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake, Am. J. Pathol., 158, 707, 10.1016/S0002-9440(10)64013-8 Ocheltree, 2005, Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice, J. Pharmacol. Exp. Ther., 35, 240, 10.1124/jpet.105.089359 Shen, 2007, Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice, Drug Metab. Dispos., 35, 1209, 10.1124/dmd.107.015263 Smith, 2004, Peptide and peptide analog transport systems at the blood-CSF barrier, Adv. Drug Deliv. Rev., 56, 1765, 10.1016/j.addr.2004.07.008 Ocheltree, 2003, Preliminary investigation into the expression of proton-coupled oligopeptide transporters in neural retina and retinal pigment epithelium (RPE): lack of functional activity in RPE plasma membranes, Pharm. Res., 20, 1364, 10.1023/A:1025741723724 Hu, 2007, Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity, J. Neurochem., 103, 2058, 10.1111/j.1471-4159.2007.04905.x Shen, 2003, Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in the choroid plexus, J. Biol. Chem., 278, 4786, 10.1074/jbc.M207397200 Courtieu, 1983, Compared sensitivities of 532 bacterial strains to six cephalosporins, Int. J. Clin. Pharmacol. Res., 3, 195 Anderson, 2001, Disorders of heme biosynthesis: X-linked siderolblastic anemia and the porphyrias, 2991 Lindberg, 1999, Motor neuropathy in porphobilinogen deaminase-deficient mice imitates the peripheral neuropathy of human acute porphyria, J. Clin. Invest., 103, 1127, 10.1172/JCI5986 Albers, 2004, Porphyric neuropathy, Muscle Nerve, 30, 410, 10.1002/mus.20137 Klassen, 2006, Heavy metals and heavy-metal antagonists, 1753 Ocheltree, 2004, Role of PEPT2 in the choroid plexus uptake of glycylsarcosine and 5-aminolevulinic acid: studies in wild-type and null mice, Pharm. Res., 21, 1680, 10.1023/B:PHAM.0000041465.89254.05 Adhikari, 2006, 5-Aminolevulinate and 4,5-diox-ovalerate ions decrease GABAA receptor density in neuronal cells, synaptosomes and rat brain, Brain Res., 1093, 95, 10.1016/j.brainres.2006.03.103 Zhang, 2004, Comparison of human and monkey peptide transporters: PEPT1 and PEPT2, Mol. Pharm, 1, 201, 10.1021/mp0499712 Fei, 1998, Molecular and structural features of the proton-coupled oligopeptide transporter superfamily, Prog. Nucleic Acid Res. Mol. Biol., 58, 239, 10.1016/S0079-6603(08)60038-0 Ganapathy, 1995, Differential recognition of β-lactam antibiotics by intestinal and renal peptide transporters, PEPT1 and PEPT2, J. Biol. Chem., 270, 25672, 10.1074/jbc.270.43.25672 Biegel, 2006, The renal type H + /peptide symporter PEPT2: structure-affinity relationships, Amino Acids, 31, 137, 10.1007/s00726-006-0331-0 Sugawara, 2000, Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2, J. Pharm. Sci., 89, 781, 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7 Ramamoorthy, 1995, Proton/peptide cotransporter (PEPT2) from human kidney: functional characterization and chromosomal localization, Biochim. et. Biophys. Acta., 1240, 1, 10.1016/0005-2736(95)00178-7 Bahadurri, 2005, Functional characterization of the peptide transporter PEPT2 in primary cultures of human upper airway epithelium, Am. J. Resp. Cell Mol. Biol., 32, 319, 10.1165/rcmb.2004-0322OC Terada, 2004, Genetic variant Arg57His in human H + /peptide cotransporter 2 causes a complete loss of transport function, Biochem. Biophys. Res. Commun., 316, 416, 10.1016/j.bbrc.2004.02.063 Pinsonneault, 2004, Genetic variants of the human H+ /dipeptide transporter PEPT2: analysis of haplotype functions, J. Pharmacol. Exp. Ther., 311, 1088, 10.1124/jpet.104.073098